Steroid hormone receptor interacting protein kinase
AssigneeBeth Israel Deaconess Medical Center, Inc.
InventorSteven Balk
Life of this patent
Estimating the term…
Abstract
The present invention features a novel p21-activated kinase that interacts with steroid hormone receptors, the steroid hormone receptor interacting p21-activated kinase (PAKSI). In general, the invention provides methods of inhibiting hormone related cancers. More particularly, the present invention relates to inhibiting prostate cancer and breast cancer. The present invention further provides methods of activating the therapeutic effects of steroid hormone receptors, particularly the estrogen receptor. Alternatively, the present invention provides methods of diagnosing steroid hormone receptor-related diseases.
Claims2
A substantially pure steroid hormone-interacting p21 GTPase activated kinase (PAKSI) polypeptide comprising SEQ ID NO:
- 2.
Dependencies are inferred from the claim text.